- Home
- NEOG vs SRRK Comparison
NEOG vs SRRK Comparison
Compare NEOG & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEOG
- SRRK
- Stock Information
- Founded
- NEOG 1981
- SRRK 2012
- Country
- NEOG United States
- SRRK United States
- Employees
- NEOG N/A
- SRRK N/A
- Industry
- NEOG Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NEOG Health Care
- SRRK Health Care
- Exchange
- NEOG Nasdaq
- SRRK Nasdaq
- Market Cap
- NEOG 3.2B
- SRRK 3.3B
- IPO Year
- NEOG 1989
- SRRK 2018
- Fundamental
- Price
- NEOG $8.61
- SRRK $31.54
- Analyst Decision
- NEOG Buy
- SRRK Strong Buy
- Analyst Count
- NEOG 2
- SRRK 7
- Target Price
- NEOG $14.00
- SRRK $40.43
- AVG Volume (30 Days)
- NEOG 4.5M
- SRRK 1.1M
- Earning Date
- NEOG 04-09-2025
- SRRK 05-06-2025
- Dividend Yield
- NEOG N/A
- SRRK N/A
- EPS Growth
- NEOG N/A
- SRRK N/A
- EPS
- NEOG N/A
- SRRK N/A
- Revenue
- NEOG $913,828,000.00
- SRRK N/A
- Revenue This Year
- NEOG $0.46
- SRRK N/A
- Revenue Next Year
- NEOG $4.12
- SRRK $599.61
- P/E Ratio
- NEOG N/A
- SRRK N/A
- Revenue Growth
- NEOG N/A
- SRRK N/A
- 52 Week Low
- NEOG $8.31
- SRRK $6.76
- 52 Week High
- NEOG $18.58
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- NEOG 41.00
- SRRK 34.34
- Support Level
- NEOG $8.31
- SRRK $31.60
- Resistance Level
- NEOG $9.04
- SRRK $33.96
- Average True Range (ATR)
- NEOG 0.35
- SRRK 1.56
- MACD
- NEOG 0.01
- SRRK -0.06
- Stochastic Oscillator
- NEOG 37.57
- SRRK 11.48
About NEOG Neogen Corporation
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.